VAM
AZN icon

Verity Asset Management’s AstraZeneca AZN Stock Holding History

Verity Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Sell
1,561
-122
-7% -$22.9K 0.11% 184
2026
Q1 		$332K Buy
1,683
+90
+6% +$17.4K 0.14% 171
2025
Q4 		$293K Sell
1,593
-1,054
-40% -$185K 0.13% 190
2025
Q3 		$406K Buy
+2,647
New +$401K 0.13% 160

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verity Asset Management's AZN Position: Q2 2026 in Review

Verity Asset Management reduced its AstraZeneca (AZN) stake by 7.2% in Q2 2026, selling an estimated $22.9K and leaving 1,561 shares worth $296K. The position accounts for 0.11% of the portfolio, ranked #184.

Verity Asset Management first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $406K in Q3 2025. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Verity Asset Management held 1,561 shares of AstraZeneca worth $296K as of Q2 2026.
  • Verity Asset Management sold 122 AstraZeneca shares in Q2 2026, an estimated $22.9K.
  • AstraZeneca made up 0.11% of Verity Asset Management's portfolio in Q2 2026, its #184 holding.
  • Verity Asset Management first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • Verity Asset Management's AstraZeneca position peaked at $406K in Q3 2025.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.